355
Views
38
CrossRef citations to date
0
Altmetric
Research Article

Comprehensive evaluation of in vitro toxicity of three large-scale produced carbon nanotubes on human Jurkat T cells and a comparison to crocidolite asbestos

, , , , , , , , & show all
Pages 319-338 | Received 24 Mar 2009, Accepted 19 Aug 2009, Published online: 30 Nov 2009

References

  • Antony PA, Restifo NP. 2005. CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2. J Immunother 28(2):120–128.
  • Belyanskaya L, Manser P, Spohn P, Bruinink A, Wick P. 2007. The reliability and limits of the MTT reduction assay for carbon nanotubes-cell interaction. Carbon 45(13):2643–2648.
  • Blank F, Rothen-Rutishauser B, Gehr P. 2007. Dendritic cells and macrophages form a transepithelial network against foreign particulate antigens. Am J Respir Cell Mol Biol 36(6):669–677.
  • Bottini M, Bruckner S, Nika K, Bottini N, Bellucci S, Magrini A, Bergamaschi A, Mustelin T. 2006. Multi-walled carbon nanotubes induce T lymphocyte apoptosis. Toxicol Lett 160(2):121–126.
  • Boyer IJ. 1989. Toxicity of dibutyltin, tributyltin and other organotin compounds to humans and to experimental animals. Toxicology 55(3):253–298.
  • Carfi M, Gennari A, Malerba I, Corsini E, Pallardy M, Pieters R, Van Loveren H, Vohr HW, Hartung T, Gribaldo L. 2007. In vitro tests to evaluate immunotoxicity: A preliminary study. Toxicology 229(1–2):11–22.
  • Casey A, Herzog E, Davoren M, Lyng FM, Byrne HJ, Chambers G. 2007. Spectroscopic analysis confirms the interactions between single walled carbon nanotubes and various dyes commonly used to assess cytotoxicity. Carbon 45(7):1425–1432.
  • Cathcart R, Schwiers E, Ames BN. 1983. Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay. Anal Biochem 134(1):111–116.
  • Cherukuri P, Gannon CJ, Leeuw TK, Schmidt HK, Smalley RE, Curley SA, Weisman RB. 2006. Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence. Proc Natl Acad Sci USA 103(50):18882–18886.
  • De la Zerda A, Zavaleta C, Keren S, Vaithilingam S, Bodapati S, Liu Z, Levi J, Smith BR, Ma TJ, Oralkan O and others. 2008. Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat Nanotechnol 3(9):557–562.
  • Dobrovolskaia MA, McNeil SE. 2007. Immunological properties of engineered nanomaterials. Nat Nanotechnol 2(8):469–478.
  • Evans J. 2007. Manufacturing the carbon nanotube market. Chemistry World 4(11).
  • Fadeel B, Kagan V, Krug H, Shvedova A, Svartengren M, Tran L, Wiklund L. 2007. There's plenty of room at the forum: Potential risks and safety assessment of engineered nanomaterials. Nanotoxicology 1:73–84.
  • Fenoglio I, Greco G, Tomatis M, Muller J, Raymundo-Pinero E, Beguin F, Fonseca A, Nagy JB, Lison D, Fubini B. 2008. Structural defects play a major role in the acute lung toxicity of multiwall carbon nanotubes: Physicochemical aspects. Chem Res Toxicol 21(9):1690–1697.
  • Fenoglio I, Tomatis M, Lison D, Muller J, Fonseca A, Nagy JB, Fubini B. 2006. Reactivity of carbon nanotubes: Free radical generation or scavenging activity? Free Radic Biol Med 40(7):1227–1233.
  • Gennari A, Ban M, Braun A, Casati S, Corsini E, Dastych J, Descotes J, Hartung T, Hooghe-Peters R, House R, 2005. The use of in vitro systems for evaluating immunotoxicity: The report and recommendations of an ECVAM workshop. J Immunotoxicol 2(2):61–83.
  • Gillis S, Watson J. 1980. Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line. J Exp Med 152(6):1709–1719.
  • Helland A, Wick P, Koehler A, Schmid K, Som C. 2007. Reviewing the environmental and human health knowledge base of carbon nanotubes. Environ Health Perspect 115(8):1125–1131.
  • Jorio A, Saito R, Dresselhaus G, Dresselhaus MS. 2004. Determination of nanotubes properties by Raman spectroscopy. Philos Transact A Math Phys Eng Sci 362(1824):2311–2336.
  • Kagan VE, Tyurina YY, Tyurin VA, Konduru NV, Potapovich AI, Osipov AN, Kisin ER, Schwegler-Berry D, Mercer R, Castranova V, 2006. Direct and indirect effects of single walled carbon nanotubes on RAW 264.7 macrophages: role of iron. Toxicol Lett 165(1):88–100.
  • Lison D, Muller J. 2008. Lung and systemic responses to carbon nanotubes (CNT) in mice. Toxicol Sci 101(1):179–80.
  • Mitchell LA, Gao J, Wal RV, Gigliotti A, Burchiel SW, McDonald JD. 2007. Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. Toxicol Sci 100(1):203–214.
  • Miyagawa H, Misra M, Mohanty AK. 2005. Mechanical properties of carbon nanotubes and their polymer nanocomposites. J Nanosci Nanotechnol 5(10):1593–615.
  • Mühlfeld C, Gehr P, Rothen-Rutishauser B. 2008. Translocation and cellular entering mechanisms of nanoparticles in the respiratory tract. Swiss Med Wkly 138(27–28):387–391.
  • Muller J, Huaux F, Fonseca A, Nagy JB, Moreau N, Delos M, Raymundo-Pinero E, Beguin F, Kirsch-Volders M, Fenoglio I, 2008. Structural defects play a major role in the acute lung toxicity of multiwall carbon nanotubes: toxicological aspects. Chem Res Toxicol 21(9):1698–1705.
  • Nemmar A, Hoet PH, Nemery B. 2006. Translocation of ultrafine particles. Environ Health Perspect 114(4):A211–212.
  • Olejniczak K, Kasprzak A. 2008. Biological properties of interleukin 2 and its role in pathogenesis of selected diseases – a review. Med Sci Monit 14(10):RA179–189.
  • Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, Seaton A, Stone V, Brown S, Macnee W, Donaldson K. 2008. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 3(7):423–428.
  • Pulskamp K, Diabate S, Krug HF. 2007. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol Lett 168(1):58–74.
  • Reynolds ES. 1963. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 17:208–212.
  • Shvedova AA, Kisin ER, Porter D, Schulte P, Kagan VE, Fadeel B, Castranova V. 2009. Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: Two faces of Janus? Pharmacol Therapeut 121(2):192–204.
  • Takagi A, Hirose A, Nishimura T, Fukumori N, Ogata A, Ohashi N, Kitajima S, Kanno J. 2008. Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci 33(1):105–116.
  • Valitutti S, Dessing M, Aktories K, Gallati H, Lanzavecchia A. 1995. Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton. J Exp Med 181(2):577–584.
  • Voelkel K, Krug HF, Diabate S. 2003. Formation of reactive oxygen species in rat epithelial cells upon stimulation with fly ash. J Biosci 28(1):51–55.
  • Warheit DB. 2008. How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? Toxicol Sci 101(2):183–185.
  • Worle-Knirsch JM, Pulskamp K, Krug HF. 2006. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett 6(6):1261–1268.
  • Zavaleta C, de la Zerda A, Liu Z, Keren S, Cheng Z, Schipper M, Chen X, Dai H, Gambhir SS. 2008. Noninvasive Raman spectroscopy in living mice for evaluation of tumor targeting with carbon nanotubes. Nano Lett 8(9):2800–2805.
  • Zeni O, Palumbo R, Bernini R, Zeni L, Sarti M, Scarfi MR. 2008. Cytotoxicity investigation on cultured human blood cells treated with single-wall carbon nanotubes. Sensors 8(1):488–499.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.